• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

National Institute for Allergy and Infectious Disease

edit

The National Institute of Allergy and Infectious Diseases (NIAID) conducts and supports basic and applied research to better understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases. For more than 60 years, NIAID research has led to new therapies, vaccines, diagnostic tests, and other technologies that have improved the health of millions of people in the United States and around the world

Recent Milestones

edit

• 
  National Institute for Allergy and Infectious Disease invested in ImmuVen. (5/1/12)
  Posted 5/1/12 at 10:04pm via finsmes.com
• 
  National Institute for Allergy and Infectious Disease invested in Maven Biotechnologies. (10/4/10)
  Posted 11/23/10 at 6:30pm via finsmes.com
• 
  National Institute for Allergy and Infectious Disease added Julie Lekstrom Himes as Academic positions.
  Posted 4/16/13 at 2:38am

Videos

Screenshots

edit

Sources

1. ImmuVen Receives $1.68M Phase II SBIR Grant (finsmes.com) [edit]
2. Maven Biotechnologies Receives $1.96M Grant from NIAID (finsmes.com) [edit]